How Previous Exposure to Disease May Help us in the Fight Against COVID-19

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

nVoq’s CEO, Charles Corfield, delves into the hypothesis of our declining immune systems and how that could be a factor in the rise of COVID-19 cases. This is our thirteenth installment of Charles’ thoughts around the current pandemic. Check back …

COVID-19: Herd Immunity and Sending Children Back to School

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

nVoq’s CEO, Charles Corfield, shares his thoughts on herd immunity and the controversial topic of sending children back to school. This is our twelfth installment of Charles’ thoughts around the current pandemic. We will usually post updates on Mondays, but …

COVID-19 Spike in Cases: What to Consider for Fall

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

In our eleventh installment of Charles Corfield’s pandemic blog, he discusses the spike in cases for COVID-19 and what we might want to consider for the Fall to help the spread. Please check back every Monday as Charles shares his …

Antibody Testing During the COVID-19 Pandemic

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

Charles Corfield, nVoq’s CEO, is back with his latest thoughts on antibody testing during the COVID-19 pandemic. Please check back weekly to read more of Charles’ thoughts. About the AuthorCharles Corfield, President & CEO, nVoq On the pandemic front, the …

New Therapies for COVID19: Ivermectin Dosing Issues

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

nVoq’s CEO, Charles Corfield, continues to provide transparency around drug research studies during the pandemic. Ivermectin was showing early promise in fighting the virus, but is the dosing within normal limits? Please check back weekly to read more of Charles’ …

New Therapies for COVID19: Why Transparency Around Drug Research is Key

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

This week, nVoq’s CEO, Charles Corfield, educates us on why transparency around drug research is so important. Please check back on Mondays to read more of Charles’ thoughts around the ongoing pandemic. About the AuthorCharles Corfield, President & CEO, nVoq …

Wake Up Words and Viral Proteins: More Similar than you Would Think

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

In this week’s pandemic blog, nVoq’s CEO, Charles Corfield illustrates how the concept of wake-up words/phrases which are usually associated with speech recognition devices might be tied to viral proteins and how that helps frame the problem that, in some …

Vaccines

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

This week in pandemic news, there is more chatter about vaccine candidates. The good news is that there are a number in the works, which increases the likelihood that at least one will make it through all the hurdles. However, …

A look at an unexpected way of gathering research through digital thermometers and how a simplistic approach might be a way to ward off the virus.

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

Charles Corfield continues his weekly COVID-19 update with a look at an unexpected way of gathering research through digital thermometers and he wonders if a simplistic approach might be a way to ward off the virus. Please check back on …

An odd correlation between cigarette smokers and COVID-19

Charles Corfield, President & CEO, nVoq Healthcare Leave a Comment

In our fourth installment of Charles Corfield’s pandemic blog, he discusses an odd correlation between cigarette smokers and COVID-19. Please check back every Monday as Charles shares his thoughts on what is trending with COVID-19. About the AuthorCharles Corfield, President …